Article info
PDFOriginal research
Development, internal validation and calibration of a risk score to predict survival in patients with EGFR-mutant non-small cell lung cancer
- Correspondence to Dr Ross Andrew Soo, Department of Hematology-Oncology, National University Cancer Institute, Singapore 119074, Singapore; ross_soo{at}nuhs.edu.sg
Citation
Development, internal validation and calibration of a risk score to predict survival in patients with EGFR-mutant non-small cell lung cancer
Publication history
- Received May 13, 2020
- Revised May 26, 2020
- Accepted May 27, 2020
- First published June 23, 2020.
Online issue publication
January 27, 2021
Article Versions
- Previous version (19 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.